Skip to main content

Table 3 MVA of OS

From: Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy

Parameters p value HR (95% CI)
Age (≥ 50 vs. <  50 years) 0.091 1.904 (0.902–4.018)
Gender (male vs. female) 0.907 1.045 (0.501–2.179)
ECOG (3–4 vs 0–2) 0.330 1.512 (0.658–3.475)
Size (≥ 5 cm vs. <  5 cm) 0.686 0.796 (0.263–2.407)
OP method (non-gross total vs. gross total) 0.887 0.950 (0.465–1.940)
RT field (whole brain vs. small) 0.322 1.510 (0.667–3.417)
Galectin-1 (strong vs. weak) 0.020 2.929 (1.180–7.271)
Galectin-3 (strong vs. weak) 0.478 1.343 (0.594–3.034)
  1. MVA multivariate statistical analysis, OS overall survival, ECOG Eastern Cooperative Oncology Group, OP operation, RT radiotherapy